Insulin Degludec/Liraglutide Combo Available in Switzerland Insulin Degludec/Liraglutide Combo Available in Switzerland

A new product combining a GLP-1 agonist with insulin degludec, which has been hailed the "most powerful combo" to date for type 2 diabetes, has been launched in its first market, Switzerland. Medscape Medical News

Source: Medscape Diabetes Headlines - January 21, 2015 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news